Статус неизвестен
Фаза III
Россия
Generex Oral-lyn™; Regular human insulin · Generex Biotechnology Corp.
A 26-Week, Open-Label, Randomized, Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin In Subjects With Type-1 Diabetes Mellitus